Biolife Solutions (BLFS) Cash from Operations (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash from Operations data on file, last reported at 491000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 128.43% year-over-year to 491000.0 in Q1 2026; TTM through Mar 2026 was 17897000.0, a 22.31% increase from a year earlier, with the FY2025 full-year figure at 20115000.0, up 138.58% from the prior year.
• Cash from Operations for Q1 2026 stood at 491000.0, down from 4916000.0 in the prior quarter.
• Over the last five years, Cash from Operations for BLFS reached as high as 7857000.0 in Q4 2022 and fell as low as 9917000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 415823.53 across 5 years, with a median of 1645000.0 in 2024.
• On a YoY basis, Cash from Operations climbed as much as 1115.12% in 2022 and fell as far as 535.38% in 2022.
• Year by year, Cash from Operations stood at 7857000.0 in 2022, then sank by 70.59% to 2311000.0 in 2023, then fell by 28.82% to 1645000.0 in 2024, then jumped by 198.84% to 4916000.0 in 2025, then sank by 109.99% to 491000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 491000.0 in Q1 2026, 4916000.0 in Q4 2025, and 6104000.0 in Q3 2025.